脂性核酸四酸盐化合物的抗病毒活性
Xiao Jia1, Dominique Schols2, Chris Meier1,3
1Organic Chemistry, Department of Chemistry, Faculty of Mathematics, Informatics and Natural Sciences, Universität Hamburg, Martin-Luther-King-Platz 6, Hamburg D-20146, Germany.
Journal of medicinal chemistry
|February 12, 2024
概括
研究人员开发了针对d4T核酸的新型核酸四酸原药. 这些前药物表现出有效释放活性代谢物和对艾滋病毒的显著抗病毒活性,证明了细胞膜通道的改善.
科学领域:
- 药用化学 医学化学
- 病毒学 病毒学
- 核酸化学 核酸化学
背景情况:
- 核糖类类似物在抗病毒疗法中至关重要,但它们的有效性可能受到细胞吸收不足和快速新陈代谢的限制.
- 前药物策略旨在提高活性药物成分的输送和治疗指数,例如d4T (stavudine).
研究的目的:
- 合成和描述新型核四酸衍生物作为d4T核酸的潜在产物.
- 评估这些前药物中活性d4T代谢物的体外释放.
- 评估这些前药物对艾滋病毒的抗病毒活性和作用机制.
主要方法:
- 合成了三种不同的d4T核四酸原药系列 (化合物4-9),具有不同的修饰.
- 使用化学和酶方法来证明d4T三酸盐 (d4TTP),δ-单基化d4T四酸盐和d4T四酸盐 (d4T4P) 的释放.
- 在CEM/TK细胞中评估了抗病毒活性,并评估了对HIV逆转录酶 (HIV-RT) 的基质活性.
主要成果:
- 在各自的前药物系列中证实了d4TTP,δ-单基化d4T四酸盐和d4T4P的有效释放.
- 令人惊的是,各种修饰的四酸盐和d4T4P被发现是HIV-RT的基质.
- 与d4T相比,TetraPPPPro-prodrug 7的抗病毒活性显著增加了7700倍,其选择性指数为5700.
结论:
- 合成的核四酸衍生物有效地作为前药物,使d4T代谢物的细胞内传递成为可能.
- 这些前药物的脂友性质有助于细胞膜通过.
- 前药7对抗病毒功效的显著增强突显了这一前药策略在开发改进的抗艾滋病毒疗法方面的潜力.
相关概念视频
DNA Base Pairing
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


